Deer Timothy R, Provenzano David A, Hanes Michael, Pope Jason E, Thomson Simon J, Russo Marc A, McJunkin Tory, Saulino Michael, Raso Louis J, Lad Shivanand P, Narouze Samer, Falowski Steven M, Levy Robert M, Baranidharan Ganesan, Golovac Stanley, Demesmin Didier, Witt William O, Simpson Brian, Krames Elliot, Mekhail Nagy
Center for Pain Relief, Charleston, WV, USA.
Pain Diagnostics and Interventional Care, Sewickley, PA, USA.
Neuromodulation. 2017 Jan;20(1):31-50. doi: 10.1111/ner.12565. Epub 2017 Jan 2.
The use of neurostimulation for pain has been an established therapy for many decades and is a major tool in the arsenal to treat neuropathic pain syndromes. Level I evidence has recently been presented to substantiate the therapy, but this is balanced against the risk of complications of an interventional technique.
The Neurostimulation Appropriateness Consensus Committee (NACC) of the International Neuromodulation Society convened an international panel of well published and diverse physicians to examine the best practices for infection mitigation and management in patients undergoing neurostimulation. The NACC recommendations are based on evidence scoring and peer-reviewed literature. Where evidence is lacking the panel added expert opinion to establish recommendations.
The NACC has made recommendations to improve care by reducing infection and managing this complication when it occurs. These evidence-based recommendations should be considered best practices in the clinical implantation of neurostimulation devices.
Adhering to established standards can improve patient care and reduce the morbidity and mortality of infectious complications in patients receiving neurostimulation.
神经刺激用于疼痛治疗已有数十年历史，是治疗神经性疼痛综合征的主要手段。最近有一级证据支持该疗法，但这与介入技术的并发症风险相权衡。
国际神经调节学会的神经刺激适宜性共识委员会（NACC）召集了一个由发表过大量论文且背景多样的医生组成的国际小组，以研究接受神经刺激患者感染预防和管理的最佳实践。NACC的建议基于证据评分和同行评审文献。在缺乏证据的情况下，小组添加专家意见以制定建议。
NACC已提出建议，通过减少感染并在感染发生时进行管理来改善护理。这些基于证据的建议应被视为神经刺激设备临床植入的最佳实践。
遵循既定标准可改善患者护理，并降低接受神经刺激患者感染性并发症的发病率和死亡率。
